INVO Bioscience (INVO) Reports Q1 results

INVO Bioscience (NASDAQ: INVO) reported Q1 revenue for the quarter at $278.14 thousand versus the consensus estimate of $257.5 thousand.

For earnings history and earnings-related data on INVO Bioscience (INVO) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Edible Garden AG (EDBL) Reports Q2 Loss of $18.79
• JD.com (JD) Reiterated at Buy by Benchmark Amid Earnings Recovery